Levente Zsembery earned his PhD in Financial Risk Management from the Budapest University of Economics in 2004, and his undergraduate degree in Finance in 1996 from the same institution. Since 1996, he has lectured at the University’s Institute of Finance. He also teaches courses in corporate finance, risk management and investment calculation at the Institute for Training and Consulting in Banking, at the Central European Training Centre for Brokers, and for MBA programs.
Dr. Zsembery served as consultant to the Ministry of Education, the Student Loan Center and later the Hungarian Development Bank (MFB), where he helped to develop and restructure the Hungarian student loan program. He advised the Budapest Stock Exchange in preparing for the unified European capital market regulation system, and served as a consultant to the Hungarian Financial Supervisory Authority (PSZÁF) in the Brau Union case.
In 2005-2006, Dr. Zsembery worked as Director of Capital Market Transactions for the Hungarian State Motorway Management Company. Between 2006 and 2010, he was Director of UniCredit CAIB Hungary, Hungary’s leading Hungarian investment bank. He was involved in significant transactions including privatization of the Hungarian airline Malév, sale of MÁV Cargo and BorsodChem subsidiaries, and the Richter Gedeon exchangeable bond issue. He has served as CEO of the Fund Management Company since 2010. Dr. Zsembery is an active member of the HVCA (Hungarian Venture Capital Association), serving as its Chairman since 2015.
Dr. Viktor Nyíri earned his LL.M. from the George Washington University in 1996. He is a 1994 graduate of the Eötvös Loránd University Law School of Budapest, and pursued post-graduate studies at the Central European University. Between 1996 and 2005, he gained experience as a lawyer, focusing on company law and M&A transactions. Since 2005 he has worked exclusively as a private investor, completing several venture capital and real estate investments individually and through his holding company, the NV Asset Management Ltd. He has wide knowledge of the health care market and an extensive network of contacts. Due to his recent investments, Dr. Nyíri is recognized as one of the primary venture capital investors in the health sector.
Tamás Varga earned a degree in Economics from the Budapest University of Economics in 1994. Mr. Varga began his career as an analyst at Rábatext Textile Company. He then gained experience as a broker at security trading companies (Lombard Bróker Kft. and DAEWOO Értékpapír Zrt.). Since 2001, Tamás has been responsible for managing the back office activities at several Hungarian fund management companies, including AEGON Magyarország Értékpapír Rt., PILIS Befektetési Alapkezelő Rt., and Biggeorge’s-NV Property Investment Fund Management Company.
Ádám Zséger has been working with the Fund Management Company since 2010, first as Analyst and now as Senior Investment Associate. Between 2008 and 2010, he worked for the Corporate Finance Department of the Magyar Posta Zrt. (Hungarian Post Plc.), where he participated in acquisition and screening projects, prepared financial analyses and business plans, and provided support for corporate management. He also assisted in setting up the company’s risk management system. He studied Business Administration (Corvinus University) and Electrical Engineering (Budapest University of Technology).
Attila Pechtol graduated in 2000 from the College of Finance and Accounting, with an emphasis on Financial Institutions. He performed analysis and controlling activities at several companies. Since 2004, he has worked as Director of Finance for the venture capital investments of Dr. Viktor Nyíri, with direct involvement in screening, preparing decisions, decision-making, monitoring and exit. Meanwhile, he obtained postgraduate certificates in Economics and Law from the Institute of Post-Graduate Legal Studies at the Eötvös Loránd University (2004), and in Corporate Management from the Corvinus University of Budapest (2009).
Illés Brigitta a Budapesti Corvinus Egyetemen szerzett master diplomát Vállalati pénzügy szakon. Az egyetemi évek alatt egy könyvelőirodánál kis- és középvállalkozások könyvelésében és pénzügyi tanácsadásában szerzett tapasztalatot. 2009 és 2010 között az UniCredit CAIB Magyarország Zrt-nél dolgozott, ahol vállalatfelvásárlási és értékesítési tranzakciókban, iparági- és vállalati elemzések elkészítésében működött közre.
After earning a medical degree from the University of Szeged, Dr. Attila Erdős began work at the Institute of Pathology as a clinician. He completed his MBA at INSEAD in 1996. From 1996 to 1999, he headed the Baltic office of SmithKlineBeecham (currently GlaxoSmithKline) and later became the European Business Development Manager at the Disease Management Division. He worked as Zone Sales Manager for GE Medical Systems in charge of Southeast Europe from 1999 to 2005 and as Managing Director of GenoID Ltd. from 2005 to 2007. At present, he is responsible for coordinating the release of products and services of several biotechnological enterprises to the international market.
Zoltán Széles obtained a degree in economics from the Szent István University of Gödöllő in 1996. He gained professional and management experience at the Budapest Fund Management Company and the K&H Securities Fund Management Company. He also worked as Supervisory Commissioner for the Hungarian Financial Supervisory Authority (PSZÁF). Between 2004 and 2006, he was Director General of Biggeorge’s–NV Property Investment Fund Management Company. While working for his own company, Unisource Ltd., he was responsible for the preparation, management and monitoring of R&D tendering projects co-financed by the Hungarian State and the European Union.
With a background in liberal arts and journalism, Mr. Nyíri joined GenoID Kft. in 2004, and was appointed the company’s Managing Director in 2007. During his term, the firm developed into one of the region’s most important laboratories for molecular diagnostics, research and forensic science.
Under Mr. Nyíri’s direction, the company achieved success in the privately funded health care market, took the lead in international R&D research consortia, had two patents accepted by the European Patent Office, and acquired unique know-how in the field of forensic genetics.
At present, Mr. Nyíri is a director of the biotech firm Neumann Diagnostics.
Péter Csíkos has over 10 years of experience in managing high-growth startups in the CEE region.
He began his career as Business Development Manager of SOLVO Biotechnology, a VC-financed Deloitte Fast50 CE Hungarian start-up company specializing in commercialization and development of in-vitro assay systems for pharmaceutical drug discovery and development. He participated in strategic planning and assisted the successful transformation of the company from a startup into a well-known service provider in the pharma and biotech industry, expanding its activities in Europe, Japan and the U.S.. He helped to win clients including the pharmaceutical manufacturers Abbott, Pfizer, Millenium and Biogen Idec.
Between 2006 and 2007, Mr. Csíkos was the head of innovations and technology transfer at Eötvös Loránd University, a major Hungarian research institution. After setting up the technology transfer program, he carried out knowledge mapping and technology screening to find, utilize, incubate and license out the selected technologies, and generated licensing revenues for the university within nine months of starting the program.
From 2007, he was the Business Development Director of ValDeal, the first technology incubator/accelerator of the CEE region. Under his interim management, six startups raised seed/early stage funding (a total of USD 12 million), various technology partnerships with key industry players were created, and by 2014, three of the portfolio companies (Gravity R&D, Medimass and Cryo-Innovation) were acquired by key industry players.
Mr. Csíkos is helping our portfolio companies in their sales and business development activities and in their international expansion.
In addition to his MBA, Gábor Bedőcs holds diplomas in the fields of IT, engineering management, and tax advisory services. Between 2000 and 2004, he worked as financial controller at Erőterv Zrt. and at Beiersdorf Kft. Since 2004, he has been responsible for Viktor Nyíri’s portfolio, overseeing its management from due diligence through the exit phase. Among other projects, he has managed investments involving the following companies: Laboratórium Ltd., GenoID, Biropharma, Omker, Naturland and Oxivit.
István Bertóti-Dohovics earned his M.S. in Finance, with an emphasis in Company Valuation, from the Budapest University of Economics in 2001. As part of the Community of European Management Schools program, he studied at the Stockholm School of Economics (1999), followed by an internship at Morgan Stanley Dean Witter in London (2000). He obtained a CEMS Master in Management degree in 2003, and the Chartered Financial Analyst (CFA) qualification in 2008.
He began his professional career at the Strategy and Business Development Department of MOL Hungarian Oil and Gas Plc., where he was involved in divestiture of non-core affiliates between 2001 and 2003. From 2003, he worked for Raiffeisen Bank: six years in real estate project financing, leveraged buy-out and syndicated lending in various industries, followed by two years as manager of the bank’s medium- and large enterprise division. During the next four years, he headed the bank’s corporate division in the areas of pre-workout and early warning.
He joined X-Ventures in 2015 with the mandate of maximizing the value of his assigned portfolio, representing the ownership interests of the fund, analyzing new investment possibilities, submitting them to the decision making body, and managing the execution of those approved by the Investment Committee.
After finishing his studies at the College of Finance and Accounting, Mr. Mester obtained a position at the Central European International Bank (today CIB Bank). Beginning in 1990, he worked in investment banking for CAIB Capital Market Advisors (and its predecessors). In 2005 he was named CEO. He brings wide experience in corporate advising, selling and acquiring companies. He participated in significant capital market transactions both in Hungary and internationally, such as the stock market listings of MOL and Matáv and the subsequent public offerings. In 2007, he served as Malév’s Deputy Director for infrastructure and portfolio management. From 2008 to 2010, he was Secretary of the National Ministry of Development and Economics in charge of competitiveness and international relations. At present, he manages international development projects for the French-owned Veolia company’s subsidiary in Hungary.
Laszlo Bicskei received an M.Sc. in Biomedical Engineering and an M.Sc. in Computer Sciences with a specialisation in Artificial Intelligence from the Budapest University of Technology and Economics in 2009. He continued his studies at the Institute of Experimental Medicine of the Hungarian Academy of Sciences, followed by a 4-years-long postgradual research project in Computational Neuroscience at University College London.
Early in his career he developed biomedical algorithms that improve patient care at Innomed Medical Inc. and General Electric. Later he worked as a life sciences management consultant at Deallus Consulting in London. As a project manager he led numerous local and global engagements across multiple therapy areas and provided in-depth commercial and technological analysis, due diligence, market opportunity assessment and brand planning.
He joined X-Ventures in 2016 with the mandate of maximizing the value of the fund’s life sciences portfolio, representing the ownership interests of the fund and analysing new investment opportunities.